DTx BERLIN 2019

DTx BERLIN 2019

3rd-4th December, 2019 | Berlin, Germany

Diving Deeper Into The Commercialisation of Digital Therapeutics

Registration Agenda

2019 Partners

Knowledge Partners
Knowledge Partner

Antwerpes develops and delivers creative marketing and communication concepts for the healthcare market – full service and with a certain disposition for forward thinking. Based in Germany, they bring experience and expertise from a demanding healthcare environment to the European setting. antwerpes employs around 145 people and belongs to the DocCheck Group.

Learn More 

Knowledge Partner

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. We strive to be the leading global business law firm by delivering quality and value to our clients.

Learn More

Knowledge Partner

EVERSANA is the leading independent provider of global services to the life science industry. From industry-leading patient service and adherence support to global pricing and revenue management, EVERSANA creates value across the life cycle for patients, prescribers, channel partners and payers.

Learn More

Knowledge Partner

We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.

 

Our three research centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in our 16 production centres around the world. 98% of Servier drugs active principles are synthesized in its own plant in Bolbec-Baclair in France. We have an active partnership policy in the field of biotechnology and we are investing in e-health through our internal WeHealth by Servier initiative.

Learn More

Supporters
Supporter

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes.

Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

Learn More.

Supporter
Supporter

JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.

We seek breakthroughs at the intersection of digital technology and neuroscience that are influencing the human experience, such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems.

Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.

 

Learn More

Supporter
Supporter

Sanofi Digital Medicine, under the Chief Medical Office, improves patient outcomes through the development of innovative technology-driven solutions that when combined with drugs, improve treatment efficacy, safety, adherence and overall experience.

Learn More

Key features
Exclusively Dedicated

Focused solely on digital therapeutics, DTx Berlin is the meeting point of this industry to overcome it’s leading challenges and define its greatest opportunities.

Deep-Dive Discussions

Quality and depth of the discussions are the foundations of DTx Berlin, with specific focus on reimbursement, scaling and implementation of digital therapeutics.

6th Event In The Series

DTx Berlin will be the sixth time the digital therapeutics industry has come together, so expect to see familiar faces and exciting newcomers.

The DTx series are the go-to events within Europe if you are truly looking to engage with the most influential stakeholders within the digital therapeutics space.

Moritz Weisbrodt - Co-Founder & CMO, Kaia Health

DTx Europe in London was critical in advancing research, distribution and reimbursement collaborations amongst key digital therapeutics stakeholders across Europe. DTx Berlin is a welcome deep dive in Germany, where new legislation provides great opportunity to bring to market the latest DTx innovations at scale and with viable business models

Elena Mustatea - CEO, Bold Health

Looking forward to addressing some of the major barriers facing the adoption of digital therapeutics at DTx Berlin – together we can bring these life changing digital therapies to patients across the globe

Simon Rowland - Head of Medical Affairs, Natural Cycles

Digital therapeutics is the next major movement within health and the DTx series is the best place to meet, collaborate and learn from other members of the industry

Gian Seehra - Investor, Optum Ventures

DTx Europe brought together inspiring speaker and attendees with a common goal: to bring digital therapeutics forward. The two days offered not only substantial insights, it also strengthened the community across the globe, bringing us closer to achieve this goal

Lina Behrens - Director Digital Drugs, Flying Health

DTx is the must-attend event in our industry

Eddie Martucci - CEO, Akili Interactive

DTx is an inclusive event, where the participants truly believe that the rising tide will raise all boats

Mette Dyhrberg - Founder and CEO, MyMee Inc.

The DTx Series is the forum where the Digital Therapeutics industry meets. The level of engagement and interaction among attendees is excellent, with discussion focused on addressing the most relevant challenges to propel the industry forward

Jim O'Donoghue - President, S3 Connected Health

The DTx Series is my go-to place for staying up-to-date and meeting all of the key players in this promising new digital health category

Bozidar Jovecevic - VP, Global Head of Digital Therapeutics, Sanofi

2019 Speakers

Gottfried Ludewig
Gottfried Ludewig
Head of Division 5, Digitalisation & Innovation
German Federal Ministry of Health
Gottfried Ludewig
Head of Division 5, Digitalisation & Innovation
German Federal Ministry of Health
Jessica Shull
Jessica Shull
European Lead
Digital Therapeutic Alliance
Jessica Shull
European Lead
Digital Therapeutic Alliance

Jessica is a Strategic Adviser to the Digital Therapeutics Alliance, whose mission is to broaden the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research. She is also Digital Health Manager on clinical trials and personalized medicine projects for respiratory disease at Bellvitge Hospital in Barcelona. She worked for more than 13 years with the WHO on numerous digital health projects for health system strengthening and digital health best practices. Consultancies include World Bank digital for global health (2010),  mHealth app evaluation guidelines for Europe (2015), and EU regulatory process for US digital diagnostic start-ups (2016). She mas a MSc from the Medical College of Georgia, an MA form the University of Trento, and is currently enrolled in the PhD program in BioMedicine at the University of Barcelona.

Dr. Wolfgang Lauer
Dr. Wolfgang Lauer
Head of the Medical Devices Division
Federal Institute for Drugs and Medical Devices (BfArM)
Dr. Wolfgang Lauer
Head of the Medical Devices Division
Federal Institute for Drugs and Medical Devices (BfArM)
Anish Shindore
Anish Shindore
Head of Digital Acceleration
Sanofi
Anish Shindore
Head of Digital Acceleration
Sanofi

Anish Shindore is the Head of Digital Acceleration at Sanofi, a company focused on
empowering lives through human health.

Anish’s focus is on driving and transforming Sanofi to create and accelerate digital therapeutics (DTx) opportunities. Prior to joining Sanofi, Anish held multiple traditional and Digital roles within both country and global commercial organizations at Novartis. Previous to his move the pharmaceutical industry, Anish held various commercial roles within the HR service industry with ADP.

Since his immersion in Pharma, Anish has been closely involved with numerous technology and software startup companies focused on health. His passion is to create digital solutions based on data where cross industry approaches can be used to derive new insights and solve complex human health problems at scale.
Over the years, Anish has been actively mentoring people from various industries, helping them to first clarify and then realize their true potential. He is current part of the faculty at Geneva Business School and an advisor to Hu-manity.co where he is creating awareness on data rights to be treated as personal property and included as our 31st Human Right.

Anish earned his MBA from ESADE and holds two bachelor’s degrees in business from Georgia State University and University of Pune.

Lina Behrens
Lina Behrens
Managing Director
Flying Health
Lina Behrens
Managing Director
Flying Health

Lina is a member of Flying Health’s Management Team as Managing Director. Flying Health pioneers business in next generation healthcare by guiding industry leaders and entrepreneurs navigate the digital healthcare system and offering an ecosystem for innovation, and by developing Digital Drugs as the next generation of digital health applications. Previously, Lina worked with payers and providers, pharma and clinical research whilst at The Boston Consulting Group and at Social Finance UK, before joining a company builder in Colombia. Lina holds an MPA from the London School of Economics, and a BA in Economics and in International Affairs from the University of St.Gallen.

Philipp Stachwitz
Philipp Stachwitz
Director, Medical Care
Health Innovation Hub
Philipp Stachwitz
Director, Medical Care
Health Innovation Hub

Philipp is an MD, trained anesthesiologist, pain therapist and the Director Medical Care of the Health Innovation Hub of the German Ministry of Health. After his specialist training in the University of Cologne and professional experience in start-ups of the dotcom era, he was in the service of the German Medical Association from 2002. There he was responsible for the development and management of the field of E-Health and telemedicine, which he served until 2008. Since 2009, he has been working in field again from the medical side first in the hospital, from 2015 as a pain therapist in the outpatient area. He actively accompanies developments in the field of electronic patient records, telemedicine, mobile health and more.

Nick Schneider
Nick Schneider
Head of Division 511, New Technologies & Data Use
German Federal Ministry of Health
Nick Schneider
Head of Division 511, New Technologies & Data Use
German Federal Ministry of Health
Vincent Hennemand
Vincent Hennemand
SVP, Strategy, Corporate and Business Development
Akili Interactive
Vincent Hennemand
SVP, Strategy, Corporate and Business Development
Akili Interactive

At Akili Interactive Labs Mr. Hennemand is currently SVP of Strategy, Corporate & Business Development, Vincent is also leading the Immuno-Inflammation Therapeutic Unit. Prior to his tenure at Akili, Vincent was previously VP Corporate Development and Operations at PureTech Health, the founding institution of Akili Therapeutic Labs.

Vincent spent a decade in Pharma at Sanofi Genzyme during which he had the opportunity to hold several positions from R&D, General Management, Manufacturing and Corporate Venture (SGBV) where he was responsible for developing and managing new investment opportunities including Myokardia, Voyager Therapeutics, WarpDrive Bio and Portal Instruments. He holds an Msc in Engineering from Ecole Nationale Superieure Arts et Metiers in France, an Msc in Bioengineering from Georgia Tech, and an MBA from MIT where he received a Martin Trust Center scholarship as Healthcare Sector Practice Leader for the Institute.

Edouard Gasser
Edouard Gasser
CEO
Tilak Healthcare
Edouard Gasser
CEO
Tilak Healthcare

Previously Studio Director at Gameloft Madrid – a company developing and editing videogames –, Edouard is leading the Tilak Healthcare team. Before heading the Madrid Creation Studio, Edouard successively worked at Gameloft as Project Manager in Paris, then Lead Producer in New Orleans. He was also a writer for TechCrunch France, covering mobile apps, 2.0 web and entertainment topics. In 2011, he co founded Productism, a social commerce website.

Rana Lonnen
Rana Lonnen
Head, Strategic Venture Capital
Novartis
Rana Lonnen
Head, Strategic Venture Capital
Novartis
Stefan Beerhalter
Stefan Beerhalter
VP of Life Sciences
German Accelerator
Stefan Beerhalter
VP of Life Sciences
German Accelerator

Stefan has many years of operative experience in various executive positions in the medical technology industry. Before joining German Accelerator Life Sciences, Stefan was in various international senior management roles, lastly as Vice President Global Marketing & Sales for CARDIONOVUM GmbH, Germany and Managing Director for OrbusNeich Medical, The Netherlands. Previously, he was the Director of Sales for ev3 and Head of Business Development for Terumo Europe. He has also worked with Getinge (Jostra), Medtronic as well as Biotronik, and held senior management positions in marketing and sales management. Stefan has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Stefan Beerhalter holds a degree in Biomedical Engineering at the Hamburg University of Applied Sciences, Germany. This was followed with a Diploma in Industrial Engineering and Management at the University of Applied Sciences, Kiel, Germany.

Stefan Zundel
Stefan Zundel
Co-Founder and Managing Director
Dopavision
Stefan Zundel
Co-Founder and Managing Director
Dopavision

Stefan is the co-founder and managing director of Dopavision, a startup developing a digital therapy for myopia (or shortsightedness), one of the most common eye disorders in the world. He’s an entrepreneur and a former strategy consultant, passionate about developing ideas that make consumers’ and patients’ lives better. Before joining the digital health space, Stefan has founded Cubitabo, an e-commerce retailer for bedroom furniture, and has previously worked as a project leader at McKinsey for consumer goods and retail clients. He holds a Master’s degree in Theoretical Mathematics and an MBA from IESE Business School in Spain.

Charlotte Lee
Charlotte Lee
Director
Big Health
Charlotte Lee
Director
Big Health
Stephan Huber
Stephan Huber
Chief Medical Officer
Kaia Health
Stephan Huber
Chief Medical Officer
Kaia Health

Stephan is the Chief Medical Officer of Kaia Health. Kaia is a manufacturer of mobile solutions for multidisciplinary rehabilitation of chronic diseases with a focus on pain and respiratory conditions.
Prior to joining Kaia Health, Stephan worked as a board-certified physician scientist at the Technical University of Munich and has published articles in several recognized journals in the field.

Christian Angern
Christian Angern
Co-Founder and Managing Director
Sympatient
Christian Angern
Co-Founder and Managing Director
Sympatient

Christian is in charge of reimbursement, business development, and sales at Sympatient. Currently, he is particularly passionate about bringing patient-centred therapies to market. He founded Sympatient during his studies at the University of Cambridge with his twin brother Julian Angern and Benedikt Reinke. Prior to Sympatient, he studied at Jacobs University and Harvard University and has worked in startups and strategy consulting.

Ciara Clancy
Ciara Clancy
CEO
Beats Medical
Ciara Clancy
CEO
Beats Medical

Dr Ciara Clancy is founder and CEO of Beats Medical, a digital therapeutics company specialising in neurological and CNS conditions. Clancy holds a degree in Physiotherapy and a PhD in Neurosurgery outcomes. Her entrepreneurial work has been internationally recognised including selection for Forbes 30 under 30, Laureate for Europe in the Cartier Awards and a finalist in the EY Entrepreneur of the Year Awards.

Simon Rowland
Simon Rowland
Head of Medical Affairs
Natural Cycles
Simon Rowland
Head of Medical Affairs
Natural Cycles

Simon Rowland is a former clinical academic doctor at Imperial College London with more than 25 international journal publications. Previously a medical advisor and therapy area lead at Bayer Plc he now leads the global medical team at Natural Cycles who have developed an FDA cleared app for contraception.

Alexandre Capet
Alexandre Capet
COO
Voluntis
Alexandre Capet
COO
Voluntis

Before joining Voluntis, Alexandre worked for over 15 years in the pharmaceutical industry. At Sanofi, he notably headed the Group’s strategic planning and M&A for France, where he strongly contributed to building the Diabeo partnership with Sanofi, CERITD and Voluntis. Alexandre is a graduate of HEC Paris and Sciences Po Paris. He holds a master’s degree in health economics from Paris-Dauphine University.

Gian Seehra
Gian Seehra
Investor
Octopus Ventures
Gian Seehra
Investor
Octopus Ventures

Gian is an investor at Octopus Ventures, focusing on the future of health. Prior to joining the Octopus Ventures team, Gian built biotechnology companies Pebble Labs and Trait Biosciences

Eitan Feniger
Eitan Feniger
VP of Connected Devices
Dario Health
Eitan Feniger
VP of Connected Devices
Dario Health

Eitan is VP of Connected Devices in DarioHealth, a global digital therapeutics leader revolutionizing the way people with chronic diseases manage their health. Eitan leads a multi-disciplinary team of professionals to deliver seamlessly integrated, clinically proven, highly engaging digital therapeutics interventions. Eitan holds a BSc. in Life Sciences from Ben Gurion University.

Lorenzo Consoli
Lorenzo Consoli
CEO & Co-Founder
NuvoAir
Lorenzo Consoli
CEO & Co-Founder
NuvoAir

Lorenzo is co-founder and CEO of NuvoAir a digital therapeutics company focused on respiratory care.
Prior to founding NuvoAir, Lorenzo worked at Novartis as Innovation Director in the Digital Solutions team. Lorenzo holds an MBA from the Wharton School, University of Pennsylvania.

Elena Mustatea
Elena Mustatea
CEO
Bold Health
Elena Mustatea
CEO
Bold Health

Elena Mustatea is Co-founder and CEO of Bold Health, a startup developing digital therapeutics for functional and autoimmune conditions, leveraging behavioural medicine and machine learning to deliver personalised and highly effective treatments and self management support. Elena was named Forbes’ Europe 30 Under 30 Finance List in 2018 in her role as venture capital investor with leading European VC fund Atomico, and previously also worked in investment banking at J.P. Morgan and Goldman Sachs, management consulting at Oliver Wyman, and ran a media business.

Lloyd Humphreys
Lloyd Humphreys
Head of Europe
Silvercloud Health
Lloyd Humphreys
Head of Europe
Silvercloud Health

Dr Lloyd Humphreys is a Clinical Psychologist by training with a business degree from the European School of Management and Technology (Berlin) and has developed, delivered and scaled a number of digital health solutions. Through this work he has been acknowledged as one of the Top 100 Health Tech Influencers and been recognized by the National Health Service for his involvement in bringing innovative technology solutions to market, being awarded one of the first NHS Innovation Accelerator Fellowships.

He has helped companies break through into the NHS as can be seen by his involvement in nearly every innovation program, from NHS Test Beds, Global Digital Exemplars, Local Health and Care Record Exemplars, NHS Apps Library, and NHS Vanguards. Beyond the UK, Lloyd has helped introduce digital health across 9 countries and 4 continents.

Michael Rosenstock
Michael Rosenstock
Head of Sana Digital
Sana Kliniken
Michael Rosenstock
Head of Sana Digital
Sana Kliniken

Michael leads Sana Digital at Sana Kliniken AG. Before his current role, he served Sana as assistant manager to the former CFO and current CEO. Michael joined Sana in 2015 after having worked with KPMG (Deal Advisory) and Rothschild (M&A). He holds a Master’s degree in Finance from the Rotterdam School of Management.

Kim Baden-Kristensen
Kim Baden-Kristensen
CEO & Co-Founder
Brain+
Kim Baden-Kristensen
CEO & Co-Founder
Brain+

Kim Baden-Kristensen is the CEO and Co-founder of Brain+, an award winning Danish health tech company specializing in digital therapeutics for brain diseases and disorders. Kim’s personal mission is to develop digital cures to brain disease. Kim is a passionate advocate for digital health, and has an active voice in the European health care policy and industry debates. His main expertise is digital therapeutics for cognitive neurorehabilitation and gamified behavioral therapy. Kim’s has a Master of Science in Economics, Innovation and Business Administration from Copenhagen Business School, a degree in Health Care Innovation from Harvard Business School, and has studied Cognitive Neuroscience and Neuropsychology at the University of Copenhagen.

Gareth Stokes
Gareth Stokes
Partner
DLA Piper
Gareth Stokes
Partner
DLA Piper

Gareth specialises in outsourcing and information technology contracts.  He has completed secondments both with a global supplier of IT and outsourcing services (Capgemini), and a leading global pharmaceutical company (GlaxoSmithKline).

Gareth has advised on numerous major outsourcing projects, including on shore within the UK, near shore within the new EU Member States and offshore in India. In addition to outsourcing, Gareth has advised on a broad range of technology projects, including system development and licensing contracts, enterprise resource planning (ERP) projects and application service provider (ASP) arrangements.

Gareth has also advised various public authorities in the healthcare and utilities spheres on a range of often politically sensitive commercial and regulatory matters, and has worked with a number of private sector organisations in their dealings with national and local government.

Silvio Riese
Silvio Riese
Digital Projects Manager
Servier
Silvio Riese
Digital Projects Manager
Servier

Silvio teams up with partners to offer therapeutic innovations to patients in need. For 10+ years, he has been driving innovations in product launch teams as well as commercial departments at Servier Germany (DTx, pharmaceuticals, digital marketing) and previously Abbott Diabetes Care (FreeStyle Libre).

Thilo Kölzer
Thilo Kölzer
CEO
Antwerpes
Thilo Kölzer
CEO
Antwerpes

Thilo Kölzer, experienced CEO with a demonstrated history of working in the digital marketing and advertising sector – always keeping an eye on Healthcare Marketing. Internet explorer since 1995. Skilled in Forward Thinking, Digital Strategy, Digital Activation and Leadership. Current issues: Digital Transformation, Seamless experience, Marketing Automation, Customized Chatbots, Multichannel and Medical Software Tools & Services.

Dennis Hermann
Dennis Hermann
VP of Business Development & Corporate Finance
Kaia Health
Dennis Hermann
VP of Business Development & Corporate Finance
Kaia Health

Dennis is VP of business development & corporate finance at Kaia Health, a start-up developing individualised digital therapies for chronic diseases with a focus on backpain and respiratory conditions.
Prior to joining Kaia Health, Dennis was the COO of Oro de Cacao, where he led the scale-up process and financing rounds, and advised clients on Private Equity and Real Estate investments at 1875 FINANCE.

2019 Agenda

  • Tuesday, 3rd December
  • Wednesday, 4th December
Tuesday, 3rd December
8.00am
Registration, Breakfast & Networking
9:00am
Chair’s Opening Remarks & Setting the Scene

Kim Baden-Kristensen, CEO & Co-Founder, Brain+

Where Are We Right Now With Digital Therapeutics? 

9:10am
Keynote - Moving Mountains: Lessons on how to crack the NHS.

Charlotte Lee, Director, Big Health 

9:35am
Presentation - A New Healthcare Mindset: Product-as-a-service.

Thilo Kölzer, CEO, Antwerpes

10:00am
Panel - Digital Therapeutics: Approval, Reimbursement and Distribution

Anish Shindore, VP, Head of Digital Acceleration, Sanofi  

Jessica Shull, European Lead, Digital Therapeutic Alliance 

Elena Mustatea, CEO, Bold Health

Gareth Stokes, Partner, DLA Piper 

10:40am
Morning Refreshments & Networking

Regulatory Approval – The Be All & End All?

11:20am
Presentation - Digital Therapeutics Deliver Evidence-Based Results ​– The DarioHealth Story

Eitan Feniger, VP of Connected Devices, Dario Health

11:45am
Presentation - Dopavision’s Mission to Treat Myopia

Stefan Zundel, Co-Founder and Managing Director, Dopavision

12.10pm
Presentation - Beats Medical Commercialising DTx for Neurological and CNS Conditions

Ciara Clancy, CEO, Beats Medical

12:35pm
Lunch & Networking

Reimbursement & Pricing

2:00pm
Presentation - Using Digital Therapeutics To Manage Respiratory Conditions

Lorenzo Consoli, CEO & Co-Founder, NuvoAir

2:25pm
Presentation - Using Virtual Reality To Treat Anxiety And Panic Disorders

Christian Angern, Co-Founder and Managing Director, Sympatient

2:50pm
Panel - What Do Digital Therapeutic Companies Need To Do To Secure Reimbursement?

Anish Shindore, Head of Digital Acceleration, Sanofi

Christian Angern, Co-Founder and Managing Director, Sympatient

Lorenzo Consoli, CEO & Co-Founder, NuvoAir

Dr. Wolfgang Lauer, Head of the Medical Devices Division, Federal Institute for Drugs and Medical Devices (BfArM)

3:35pm
Afternoon Refreshments & Networking

A Deep-Dive Into The German Landscape

4.25pm
Presentation - Insights Into The Federal Ministry of Health's Journey to Digitalise The German Healthcare System

Dr. Gottfried Ludewig, Head of Division 5, Digitalisation & Innovation, German Federal Ministry of Health 

4:55pm
Panel - What Needs To Change For Digital Therapeutics To Be Successfully Adopted In Germany?

Moderated by Lina Behrens, Managing Director, Flying Health 

Nick Schneider, Head of Division 511, New Technologies & Data Use, German Federal Ministry of Health

Stefan Beerhalter, VP of Life Sciences, German Accelerator

Dennis Hermann, VP of Business Development & Corporate Finance, Kaia Health 

5:35pm
Drinks Reception - Hosted by Eversana
6:40pm
Close of Day 1
Download Full Agenda
Wednesday, 4th December
8:00am
Breakfast & Networking
9:00am
Chair’s Opening Remarks

Lina Behrens, Managing Director, Flying Health 

9:10am
Keynote - Lessons Learnt From The Frontline of Digital Therapeutics

Vincent Hennemand, SVP, Strategy, Corporate and Business Development, Akili Interactive

Scaling Digital Therapeutics in Europe

9:35am
Presentation - Digital Therapeutics Need Credible Partnerships

Silvio Riese, Digital Projects Manager, Servier 

10:00am
Presentation - Treating Chronic Back Pain Using Multimodal Therapy

Dennis Hermann, VP of Business Development & Corporate Finance, Kaia Health 

10:25am
Panel - What Is The Best Route To Take When Scaling Digital Therapeutics?

Dennis Hermann, VP of Business Development & Corporate Finance, Kaia Health 

Vincent Hennemand, SVP Strategy Corporate and Business Development, Akili Interactive

Edouard Gasser, CEO, Tilak Healthcare

Alexandre Capet, COO, Voluntis

11:10am
Morning Refreshments & Networking

Implementing Digital Therapeutics Into European Healthcare Systems

11.45am
Presentation - Improving Mental and Behavioural Health Across Europe

Lloyd Humphreys, Head of Europe, Silvercloud Health

12.10am
How Can We Boost The Implementation Of Digital Therapeutics Into European Healthcare Systems?

Moderated by Gian Seehra, Investor, Octopus Ventures

Charlotte Lee, Director, Big Health 

Simon Rowland, Head of Medical Affairs, Natural Cycles

Philipp Stachwitz, Director, Medical Care, Health Innovation Hub

Michael Rosenstock, Head of Sana Digital, Sana Kliniken

12:55pm
Lunch & Networking

Turning Digital Therapeutics from a Novelty to a Money Maker

1:50pm
Panel - How Can We Turn Digital Therapeutics From a Novelty to a Money Maker?

Rana Lonnen, Head, Strategic Venture Capital, Novartis

Ciara Clancy, CEO, Beats Medical

Gian Seehra, Investor, Octopus Ventures

2:35pm
Chair’s Summary

Lina Behrens, Managing Director, Flying Health 

2:45pm
Close of DTx Berlin 2019
Download Full Agenda
Industry Partner
Flying Health

Flying Health pioneers business in next generation healthcare since its foundation in 2012. We help industry leaders and entrepreneurs navigate the digital healthcare system, offer an ecosystem for innovation and provide experienced corporate foresight. But Flying Health doesn’t only talk about the future. With our Digital Drugs spinoffs, we actively develop the next generation of digital health applications.

 

Learn More

Partner with us

The DTx summits are the home for the key decision-makers in the rapidly growing Digital Therapeutics industry to meet, learn and connect.

DTx Berlin is the 6th event in the series – starting in the U.S., and more recently expanding across Europe.  We have a limited number of Partnership positions available for forward-thinking companies who want to get involved with this senior-level audience.

To discuss options available, or to learn more about the event please get in touch.

Contact Us +
Partner with us

Register for the Event

For pricing and booking options please click the button to go to the registration page.

Registration